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Prevention of dialysis disequilibrium syndrome
by use of high sodium concentration in the dialysate
FRIEDRICH K. PORT, WILLTAM J. JOHNSON and DONALD W. KLASS
Mayo Clinic and Mayo Foundation, Rochester, Minnesota
Prevention of dialysis disequilibrium syndrome by use of high
sodium concentration in the dialysate. Nine patients, including
four undergoing their first hemodialysis, were observed clinically
and by hourly electroencephalographic recordings before, during,
and three hours after highly efficient hemodialyses dLlring which
plasma osmolality was maintained by use of a dialysate with
increased concentrations of sodium and chloride. As a control
group, 8 patients (five undergoing their first hemodialysis) were
similarly studied but with a dialysate of standard composition
(Na= 133 mEq/litcr). The EEG showed definitely increased
abnormality in 10 of 13 control dialyses and in 2 of 9 dialyses
in the experimental group (P <0.01). Symptoms suggestive of the
dialysis disequilibrium syndrome appeared in nine of the control
dialyses but in none of the experimental group (P <0.001). No
ill effects from increased dialysate sodium concentration could
be demonstrated during or after a single hemodialysis.
Prevention du syndrome de déséquilibre de la dialyse au moyen
d'une concentration de sodium élevée dans le dialysat. Neuf mala-
des, dont quatre subissaient leur premiere hémodialyse, ont été
observes cliniquement et au moyen d'enregistrements électro-
encéphalographiques horaires pendant et trois heures après des
hémodialyses trés efficaces ofi l'osmolalitC plasmatique était
maintenue constante grace a un dialysat dont les concentrations
de sodium et de chlore étaient augmentées. Un groupe contrôle
de 8 malades, dont cinq subissaient leur premiere hémodialyse,
a été étudié de Ia méme facon alors quo le dialysat avait une
composition standard (Na= 133 mEq/l). L'électroencephalo-
gramme a montré une augmentation patente des anomalies chez
10 des 13 contrôles et chez deux des neuf sujets do groupe
experimental (P <0.01). Des symptomes suggérant un syndrome
de désequilibre au cours de Ia dialyse sont apparus chez neuf
sujets du groupe contrôle mais seulement chez un sujet du
groupe experimental (P<O.00l). Aucun effet nuisible do a
l'augmentation de Ia concentration du sodium n'a pu être mis
en evidence pendant ou après une unique hemodialyse.
The dialysis disequilibrium syndrome is a clinical dis-
order occurring during or immediately after dialysis. Its
symptoms and signs range from frequent minor symptoms
such as headache, nausea, vomiting, and drowsiness to
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more severe disorders such as asterixis, involuntary jerking
movements, disorientation, psychosis, convulsions, and
coma. Paradoxically, these unfavorable clinical disorders
develop while the chemical abnormalities in the blood are
improving [1, 2]. The disorder is accompanied by deterio-
ration of the electroencephalogram with slowing of basic
rhythms and paroxysmal discharges, suggesting that the
clinical manifestations are attributable to cerebral dys-
function [2, 3]. The disorder is most likely to occur in
severely uremic patients undergoing their first hemodialysis,
particularly when highly efficient dialyzers are used and
biochemical abnormalities are corrected rapidly [2, 4, 5],
or when the patient has a preexisting neurologic disorder
[6].
The pathogenesis of this disorder is in dispute, but the
most widely accepted explanation is that overhydration of
cells in general and of the brain in particular is caused by an
osmotic gradient at the cell wall. During dialysis, the
osmolality decreases rapidly in the extracellular fluid and
decreases more slowly in the intracellular space, creating
an osmotic gradient which favors a shift of water into the
cells [3, 7—9].
This study was designed to determine whether main-
tenance of plasma osmolality would prevent the develop-
ment of serious symptoms of the disequilibrium syndrome
during highly efficient hemodialysis. The osmotic agent
used to compensate for the decrease in blood urea was
sodium chloride.
Methods
Seventeen patients with severe renal failure were selected
for study during 22 hemodialyses. Nine of these dialyses
were assigned to the experimental and 13 to the control
group. Selection was randomized except for an attempt to
allow approximately equal predialysis blood urea concen-
trations in both groups. Four patients in the experimental
and five in the control group were studied during their first
hemodialysis, which was performed when endogenous
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creatinine clearance had diminished to values below 5 ml!
mm/I .73 m2. The remaining patients were already being
maintained by chronic hemodialysis. Five patients were
studied under both "experimental" and "control" con-
ditions. The ages of all patients ranged from 17 to 61 years
with a mean of 37 years for both groups.
Prior to this study, arbitrary criteria were established.
Dialysis disequilibrium was considered to be present if
three of the minor, two of the moderate, or one of the
severe symptoms or signs developed during dialysis
(Table 1). Only the appearance of findings which were not
present prior to dialysis was accepted.
Table 1. Symptoms and signs used as criteria for dialysis dis-
equilibrium syndrome
Minor
Headache; vomiting; drowsiness; restlessness; muscle cramps
Moderate
Asterixis; myoclonus; disorientation; somnolence
Severe
Psychosis; convulsion; stupor or coma
Electroencephalograms, including response to photic
stimulation, were recorded with an eight-channel electro-
encephalograph (Grass Model 6) at hourly intervals before,
during, and three hours after dialysis (for total periods of
eight hours). The electroencephalograms were interpreted
independently by one of us (D.W.K.) without knowledge of
dialysate composition or clinical symptoms. Recordings
were classified by composite characteristics as normal or as
abnormal, and abnormalities were divided into three grades
based on severity according to the Mayo classification
system [10]. Classification was based on portions of the
tracings obtained after alerting to ensure comparability
among recordings and to exclude simulated abnormality
from frequency shifts associated with drowsiness, a
common circumstance during dialysis.
Biochemical analyses of arterial blood were performed,
before and after dialysis, for blood urea, glucose, plasma
creatinine, uric acid, calcium, magnesium, phosphorus,
chloride, and acid-base balance. Plasma osmolality, sodium,
and potassium were measured at half-hour intervals through-
out dialysis and three hours after dialysis. Plasma osmolality
was measured in duplicate by the freezing point depression
method. Serum sodium and potassium were measured by
flame photometry in triplicate. Other measurements were
performed by routine laboratory methods.
For high efficiency, two Mini-Kiil dialyzers1 were used
in series with blood flows maintained at 250 mI/mm by
a blood pump and a countercurrent dialysate flow of 1,000
mI/mm from a central tank also in serial circuit. The mem-
brane area totaled 1.28 m2. The duration of dialysis was
1 Life-Med Mini-Kiil Dialyzers, D3, Life Med Corp., Campton,
Calif., U.S.A.
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Fig. 1. Curves used to calculate increase in plasma sodium con-
centration necessary to compensate for osmotic effect of decrease
in blood urea concentration during a 4-hr dialysis, shown for
three different dialysance values (D).
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Fig. 2. Range of blood values during and immediately after dia-
lysis. Individual cases are shown by horizontal lines at 0 and
4 hr. Scales of ordinates are adjusted so that vertical distance
is equivalent to same osmotic effect on all plots. Note that blood
urea rather than urea nitrogen values are used.
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four hours. The dialysance for urea averaged 165 mi/mm
with a mean decrease in blood urea concentration of 59 %.
The negative pressure in the dialysate compartment ranged
from 20 to 40 mm Hg. For the control group, a standard
dialysate was used containing (per liter): sodium, 133 mEq;
potassium, 1 mEq; calcium, 3 mEq; magnesium, 1 mEq;
chloride, 108 mEq; acetate, 33 mEq; and glucose, 2 g. The
experimental group was dialyzed against a bath of standard
composition but with increased concentrations of sodium
and chloride achieved by constant infusion of hypertonic
saline (3 to 5 g/100 ml) into the dialysate line. Since this
infusion contributed less than 3 % to the volume of the
dialysate, it did not significantly alter the concentrations of
the other solutes in the dialysate, but it increased sodium
and chloride concentrations in the dialysate to a constant
level throughout dialysis. The rate of infusion was adjusted
individually in order to achieve an increase in plasma so-
dium concentration during dialysis sufficient to compensate
for the osmotic effect of a decreasing urea concentration
and thus prevent a significant change in plasma osmolality.
The calculated values for this "A plasma sodium" concen-
tration are shown in Fig. 1; however, a dialysate sodium
concentration 2 mEq/liter higher than the sum of "A plasma
sodium" and predialysis plasma sodium concentration was
selected to allow for the fact that equilibration of dialysate
and plasma sodium is incomplete during a 4-hour dialysis.
Results
Changes in plasma osmolality, plasma sodium, and blood
urea for all patients during the four hours of dialysis and
the three hours after dialysis are shown in Fig. 2. In the
experimental group, plasma osmolality was successfully
maintained within a narrow range. The control group show-
ed a marked decrease in plasma osmolality and a slight
decrease in plasma sodium concentration. The decrease in
blood urea was similar for both groups.
Blood chemical data and changes are shown in Table 2.
Dialysate sodium concentrations and changes in plasma
osmolality and sodium concentrations showed highly
significant differences; the other factors were similar for
both groups.
New symptoms or signs observed during or within three
hours after dialysis are listed in Table 3. None of the nine
patients dialyzed against the higher sodium dialysate ful-
filled our predetermined clinical criteria for the dialysis
disequilibrium syndrome, despite rapid hemodialysis;
nine of the 13 patients dialyzed against standard dialysate
fulfilled these criteria (for this difference, P<0.001). Of
patients studied during their first dialysis, there were four
of five in the control group and none in the experimental
group who fulfilled our criteria for this syndrome.
In confirmation of the clinical findings, the electro-
encephalogram (EEG) showed deterioration in only two
Table 2. Effect of dialysis: Comparison of study groups (Means SD)
Observation
Predialysis data Changes during dialysisa
Experimental ControlExperimental Control
group group group group
(N=9) (N=13) F (N=9) (N=13) F
Dialysate sodium 149.3±6.0 133.1±2.6 <0.001 Constant Constant ...
mEq/liter
Plasma osmolality 307.1 18.9 315.0± 17.1 >0.05 — 5.8± 2.7 —25.6± 12.9 <0.001
mOsm/kg
Plasma sodium 136.3±4.1 140.8± 3.2 0.01 +7.5±5.4 —2.2± 2.6 <0.001
mEqiliter
Blood urea 190.2 101.6 179.0 68.4 >0.05 —114.5 13.3 —106.3 15.3 >0.05
mg/100 ml
Plasma creatinine 13.4± 4.4 14.0± 3.2 >0.05 —7.0± 3.1 —7.9± 2.2 >0.05
mg/100 ml
Blood glucose 121.8± 19.6 117.6± 20.9 >0.05 — 15.8± 19.2 — 11.4± 28.5 >0.05
mg/100 ml
Plasma potassium 4.9± 1.0 5.1±0.8 >0.05 —1.8±0.7 —2.1±0.8 >0.05
mEq/Iiter
Plasma calcium 8.3 1.6 9.1 0.8 >0.05 + 1.4± 1.1 + 1.9 0.8 >0.05
mg/100 ml
Plasma magnesium 2.44±0.67 2.64±0.51 >0.05 —0.46±0.30 —0.55±0.28 >0.05
mg/100 ml
Plasma phosphorus 6.1 3.3 5.8 3.5 >0.05 —2.1 2.2 —2.0 1.7 >0.05
mg/100 ml
Blood pH 7.35±0.04 7.37± 0.06 >0.05 +0.08±0.03 +0.11± 0.04 >0.025
BloOdPco 43.1±7.7 39.8±5.4 >0.05 —8.9±7.0 —9.1±3.8 >0.05
mm Hg
Blood hematocrit 21.9±4.2 21.8±4.7 >0.05 —0.9±4.1 +0.1 1.7 >0.05
%
a — designates decrease; + designates increase.
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Table 3. New symptoms or signs observed
dialysis
during or after
Sign
or
Symptom
Experimental
group
(N= 9)
Control
group
(N== 13)
Headache 1 9
Vomiting 2 5
Drowsiness 3 2
Restlessness 0 5
Asterixis 2 5
Myoclonus 0 1
Psychosis 0 1
Met criteria 0 9
for syndrome
of the nine patients in the experimental group, while ten of
13 patients in the control group showed EEG deterioration
(Figs. 3 and 4) of one grade or more (for this difference,
P <0.01). The two patients with EEG deterioration in the
experimental group were studied during their first hemo-
dialysis while four of the five patients of the control group
had EEG deterioration during their initial dialysis.
The plasma sodium concentration in the experimental
group reached an average of 144 mEq/liter during dialysis
(mean increase, 7.5 mEq/liter) and a maximum of 154
mEq/liter in one patient. This increase was not accom-
panied by pulmonary congestion, aggravation of hyper-
tension, or weight gain. Pulmonary congestion could not
be found at the end of dialysis or three hours later. Diastolic
blood pressures decreased by a mean of 8 mm Hg in both
groups while systolic pressures increased by 11 mm Hg
in the experimental group and by 2 mm Hg in the control
group. Body weights diminished during dialysis by means
of 0.58 and 0.67 kg, respectively.
At the start of the subsequent dialysis, an average of two
days later, body weight and blood pressure (supine posi-
tion) were compared with those at the end of the previous
dialysis. Body weight increased in the experimental group
by an average of almost 0.5 kg per day, which corresponds
well to the expected increase between dialyses in our ex-
perience with "standard" dialysate. In the control group,
the mean change in weight was less than 0.05 kg per day.
Systolic blood pressures decreased by an average of 8 and
15 mm Hg while diastolic readings increased by 7 and
4 mm Hg, respectively, in the experimental and control
groups.
Discussion
The exact pathogenetic mechanism for the dialysis dis-
equilibrium syndrome is not clearly understood [4]. Al-
though this experiment was not designed to study the patho-
genesis of the disorder but to test a method for its preven-
tion, the results are consistent with the hypothesis that an
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Fig. 3. EEG tracings from 41 year-old woman in control group (standard dialysate) who developed the disequilibrium syndrome.
Note normal recording before dialysis (Upper Left) and increasing abnormalities consisting of slower frequencies during dialysis
(grade 1 in Upper Middle, grade 2 in Upper Right) and after dialysis (grade 3 in Lower).
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Fig. 4. EEG tracings from 51 year-old man
(A) before and (B) during dialysis. I, in
experimental group (dialysate with added
saline); II, in control group (standard
dialysate). Upper, No change from normal
during first dialysis. Lower, Change from
normal to abnormal (grade 3, paroxysmal)
during later dialysis.
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osmotic gradient at the cell wall, induced by dialysis, may
be a major etiologic factor. Alternative explanations include
a direct effect of sodium, changes in extracellular fluid
volume, ionic gradients at the cell wall, and peripheral
effects. Direct measurements of water movement and com-
position of the brain would be required for proof of such
hypotheses.
Kennedy et al [11] and Scheitlin and Hunziker [8] were
among the first to call attention to the dialysis disequili-
brium syndrome, attributing it to a rapid decrease in blood
urea concentration. Alwall [12] attributed the findings of
Kennedy's group to water intoxication related to the use of
the "rotating drum kidney" which was highly efficient in
its removal of urea but incapable of ultrafiltration. Maher
and Schreiner [13] also suggested that the disorder is more
commonly encountered with the rotating drum dialyzer
than with the twin-coil artificial kidney. This may be related
to other factors such as greater severity of azotemia in the
early days of hemodialysis. The use of less efficient dialysis
with shorter periods of dialysis as a means of preventing
the disorder has been advocated [1, 2, 6].
Another approach to prevention of the dialysis dis-
equilibrium syndrome has been the addition, to the dia-
lysate, of an osmotic agent capable of blocking the move-
ment of urea into the bath [6, 7, 14] or of diffusing into the
bloodstream and thereby also preventing a decrease in serum
osmolality [15]. Osmotic agents commonly used to counter-
act urea include glucose [7, 16, 17], fructose [7], and manni-
tol [18, 19].
Several objections may be raised to the use of urea. One
of the purposes of dialysis is to remove protein catabolites,
including urea. While urea is not highly toxic, it appears to
contribute to some of the minor symptoms of the uremic
syndrome, such as headache, nausea, and vomiting, and
to play a role in the bleeding tendency [20]. In addition, it
seems doubtful that a decrease in the blood urea concen-
tration is solely responsible for the dialysis disequilibrium
syndrome. In experimental animals, urea loading followed
by rapid dialysis produces the anticipated osmotic gradient
between cerebrospinal fluid and blood with a significant
increase in spinal fluid pressure but without EEG changes
[21, 22].
Recent studies by Arieff et al [23] using uremic dogs
indicated that during slow dialysis there were no significant
osmotic gradients between plasma, brain, and spinal fluid
and no increase in brain water or cerebrospinal fluid pres-
sure but, in rapidly dialyzed animals, significant osmotic
gradients were established between plasma, cerebrospinal
fluid, and brain with increases in cerebrospinal fluid pres-
sure and brain water content. However, they were unable
to explain these changes on the basis of changes in concen-
tration of sodium, potassium, or urea; they attributed over-
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hydration of the brain to generation of unidentified osmo-
tically active substances within the brain during dialysis.
Uremic patients maintained by regular hemodialysis
against a high concentration of urea in the dialysate showed
only mild symptoms of the dialysis disequilibrium syndrome
and no EEG deterioration after rapid decrease of blood
urea [20]. Thus, although changes in urea concentration
play a major role, they are not the sole cause for the clinical,
physiologic, or BEG abnormalities observed during rapid
dialysis [9, 14, 20, 21, 24].
Glucose has been widely used as an osmotic agent in
dialysates [16, 17]. There are dangers in the use of high
concentrations of glucose, such as severe hyperglycemia and
hyperosmolality [25] in patients incapable of metabolizing
glucose rapidly, or the rapid decrease in glucose concen-
tration and in osmolality after discontinuation of dialysis
which may induce a delayed disequilibrium syndrome with
seizures [17, 26] or hypoglycemia [27]. Fatalities have
occurred during dialyses in which high concentrations of
glucose were used [28, 29]. In any case, carefully controlled
studies by Hampers et al [24] and Gutman et a! [26] failed
to show any consistent beneficial effects from a high glucose
concentration in the dialysate.
Fructose and mannitol have been proposed because of
their slow metabolism [7, 19]. In their extensive studies using
mannitol infusions during dialysis, Hagstam et a! [19]
found that the only consistent beneficial effect was the
prevention of muscle cramps.
To our knowledge, sodium chloride has not been pro-
posed as an osmotic agent for prevention of the dialysis
disequilibrium syndrome, yet it is known [30] that sodium
diffuses more slowly across the blood-brain barrier than
urea and that its physiologic effect is of greater duration.
A relatively small change in sodium concentration (for
example, 1 mEq/liter) can offset the osmotic effect of a
seemingly large change in blood urea concentration (12 mg
/100 ml). During dialysis, sodium and chloride ions can
be removed by ultrafiltration, thereby decreasing the ten-
dency toward increase in total body sodium which might
precipitate complications such as acute pulmonary edema
and hypertensive crisis. Our interest in sodium as an os-
motic agent was stimulated by the articles by Gonzalez
et a! [31] and Sokol et a! [32] in which severe forms of the
dialysis disequilibrium syndrome were described in hyper-
tensive patients after the use of a low sodium concentration
in the dialysate. Pappius et al [9] and Wakim et al [21, 22]
were able to produce BEG changes in dogs simulating
those of the dialysis disequilibrium syndrome by dialyzing
them against low sodium concentrations in the dialysate.
Shaldon [5] found a high incidence of dialysis disequilibrium
syndrome in patients with high predialysis serum sodium
concentrations, which may suggest that the greater decrease
in serum sodium during dialysis is a contributing factor.
Edel et al [33] found a low incidence of this syndrome and
a small osmotic gradient from plasma to cerebrospinal
fluid. However, their center used a dialysate sodium concen-
tration of 148 mEq/liter which is higher than that used in
most centers.
Accidental use of a high sodium concentration in the
dialysate was reported by Lackenschweiger and Zimmer-
man [34]. In their center, five patients were d'ilyzed in-
advertently against a sodium concentration of 154 mEq/
liter repeatedly for one month but showed surprisingly few
side effects.
Our findings of the absence of excessive weight gain,
pulmonary congestion, or aggravation of hypertension also
demonstrate the infrequency of complications from
moderate increases in plasma sodium concentration in a
single dialysis. This may be explained by the fact that
plasma sodium may increase during dialysis without the
diluting effect of water from the intracellular space when
plasma osmolality is not significantly increased. The use
of higher ultrafiltration also could decrease the problem of
volume overload. In repeated dialysis, the use of high
sodium dialysate has not been completely evaluated and
may be hazardous.
Although this study did not measure the composition of
cerebrospinal fluid or brain or the movements of water,
the clinical results suggest that major manifestations of the
dialysis disequilibrium syndrome can be prevented by
maintenance of plasma osmolality through an appropriate
increase in dialysate sodium concentration. The level of
dialysate sodium may be adjusted individually, thus allow-
ing only a minimal variation in plasma osmolality. Such an
adjustment in dialysate sodium concentration seems useful
with the first hemodialysis, particularly in patients who are
highly susceptible, such as those with greatly increased blood
urea concentrations or with cerebral disorders.
Reprint requests to Dr. Friedrich K. Port, Mayo Clinic and
Mayo Foundation, Rochester, Minnesota 55901, U.S.A.
References
1. TYLER HR: Neurologic disorders in renal failure. Am J Med
44:734—748, 1968
2. MERRILL JP, HAMPERS CL: Uremia: Progress in Pathophysio-
logy and Treatment, New York, Grune & Stratton, Inc., 1971
3. JACOB JC, GLOOR P, ELWAN OH, DOSSETOR JB, PATERAS
VR: Electroencephalographic changes in chronic renal fai-
lure. Neurology 15:419—429, 1965
4. DOSSETOR JB, GAULT MH: Neiihron Failure: Conservation,
Substitution, Replacement, Sprirgfield, Illinois, Chas C Tho-
mas, 1971, p. 181
5. SHALDON S: Haemodialysis in chronic renal failure. Postgrad
Med J Suppl November 1966, p. 3
6. PETERSON H DE C, SWANSON AG: Acute encephalopathy
occurring during hemodialysis: The reverse urea effect. Arch
Intern Med 113:877—880, 1964
7. KENNEDY AC, LUKE RG, LINTON AL: Dialysis disequili-
brium syndrome in Acute Renal Failure, edited by SHALDON
S, COOK GC, Philadelphia, F. A. Davis Company, 1964,
p.65
Dialysis disequilibrium syndrome 333
8. ScHEITLIN W, HUNZIKER A: Die Beeinflussung des Liquor-
chemismus durch Hamodialyse beim urämischen Patienten.
Schweiz Med Wochenschr 92:673—676, 1962
9. PAPPIUS HM, Oii JH, DOSSETOR JB: The effects of rapid
hemodialysis on brain tissues and cerebrospinal fluid of
dogs. Canad J Physiol Pharmacol 45:129—147, 1967
10. Department of Neurology and Department of Physiology
and Biophysics, Mayo Clinic and Mayo Foundation: Clinical
Examinations in Neurology, 3rd ed., Philadelphia, W. B.
Saunders Cu, 1971, p. 259
11. KENNEDY AC, LINTON AL, EATON JC: Urea levels in cere-
brospinal fluid after haemodialysis. Lancet 1:410—411, 1962
12. ALWALL N: Discussion in Acute Renal Failure, edited by
SHALDON S, COOK GC, Philadelphia, F. A. Davis Co, 1964,
p.77
13. MAHER JF, SCHREINER GE: Hazards and complications of
dialysis. N Eng .1 Med273: 370—377, 1965
14. HöFFLER D, OPITz A, SCHAEFER K, KNOOP H, KNUTI-1 0,
QUELLHORST E, HENNING HV, SCHELER F: Die chronische
Hamodialyse: Fin Erfahrungsbericht uber 4614 Hamodialy-
sen bei 59 Patienten. Arch KIm Med 216:324—354, 1969
15. WAKIMKG: The pathophysiology of the dialysis disequili-
brium syndrome. Mayo C/in Proc 44:406—429, 1969
16. BENNHOLD I, Kullicxi 5, KESSEL M: The influence of glucose
concentration in the dialysate on the electroencephalograms
of uraemic patients. Internat Congr Series No. 103, Amster-
dam, Excerpta Medica, 1965, p. 13
17. DRUKKER W, ALBERTS C, JUNGERIUS NA: Dialysate glucose
concentration and plasma osmolality during haemodialysis
in acute renal failure. Internat Congr Series No. 103, Amster-
dam, Excerpta Medica, 1965, p. 7
18. BRADEURY MWB, STuBB5 J, HUGHES IF, PARKER P: The
distribution of potassium, sodium, chloride and urea be-
tween lumbar cerebrospinal fluid and blood serum in human
subjects. Cliii Sci 25:97—105, 1963
19. HAGSTAM KE, LINDERGARD B, TIBBLING 0: Mannitol inf u-
sion in regular haemodialysis treatment for chronic renal
insufficiency. Scand J Urol Nephrol 3:257—263, 1969
20. JOHNSON WJ, HAGGE WW, WAGONER RD, DINAPOLI RP,
ROSEVEARJW: Effects of urea loading in patients with
far-advanced renal failure. Mayo Clin Proc 47:21—29,
1972
21. WAKIM KG, JOHNSON WJ, KLASSDW: Role of blood urea
and serum sodium concentrations in the pathogenesis of the
dialysis dysequilibrium syndrome. Trans Am Soc Art if Intern
Organs 14:394—400, 1968
22. WAKIM KG: Predominance of hyponatremia over hypo-
osmolality in simulation of the dialysis disequilibrium syn-
drome. Mayo C/in Proc 44:433—460, 1969
23. ARIEFF Al, BARRIENTOS A. MASSRY SO, et al: Brain H20
and electrolytes in uremic dogs: effects of slow and rapid
hemodialysis (HD) (abstract). Abstracts of V Annual Meeting
of Am Soc Nephrol, November 22—23, 1971, Washington,
DC, p.4
24. HAMPERS CL, DOAK PB, CALLAGHAN MN, TYI.ER HR, MER-
RILL JP: The electroencephalogram and spinal fluid during
hemodialysis. Arch Intern Med 118:340—346, 1966
25. MENDELSSOHN S, SWARTZ CD, Yuos M, ONE5TI G, RAMI-
REZ 0, BREST AN: High glucose concentration dialysate in
chronic hemodialysis. Trans Am Soc Artif Intern Organs
13:249—253, 1967
26. GUTMAN RA, HICKMAN RO, CHATRIAN GE, SCRIBNER BH:
Failure of high dialysis-fluid glucose to prevent the disequi-
librium syndrome. Lancet 1:295—298, 1967
27. RIGG GA, BERCUBA: Hypoglycemia: a complication of
hemodialysis. NEng J Med 277:1139—1140, 1967
28. KERR DNS: Discussion in Acute Renal Failure, edited by
SHALDON 5, COOK GC, Philadelphia, F. A. Davis Co, 1964,
p.78
29. POTTERDJ: Death as a result of hyperglycemia without
ketosis: a complication of hemodialysis. Ann Intern Med
64:399—401, 1966
30. FUNDER J, WIETH JO: Changes in cerebrospinal fluid com-
position following hemodialysis. Scand J C/in Lab Invest
19:301—312, 1967
31. GONZALEZ FM, PABIc0 RC, BROWN HW, MAHER JF,
SCHREINER GE: Further experience with the use of routine
intermittent hemodialysis in chronic renal failure. Trans Am
Soc Artif Intern Organs 9:11—17, 1963
32. SOKOL A, GRAL T, RUBINI ME: Some medical problems of
chronic hemodialysis. Calif Med 107:236—246, 1967
33. EDEL HH, GURLAND HJ, RENNER F, EIGLER J, BUCHIIORN
E: Das Verhalten der Blut-Liquorgradienten bei Azotämie
und ihre Beeinflussung durch die Hamodialyse. Klin Wo-
chenschr 43:1081—1086, 1965
34. LACKENSCHWEIGER A, ZIMMERMAN E: Hamodialyse bei ver-
schiedenen Na-Konzentrationen in der Spulflussigkeit. Wien
ZInn Med 49:68—70, 1968
